Nissha medical technologies sas registration number: (b)(4).A foreign manufacturer located in france ("nissha medical sas") identified a failure of the claravue patient monitoring device family that transmits patient monitoring signals to third-party devices ("ip set") to perform to an established specification.Testing performed internally and by a third-party potential customer related to product development identified that one portion of the ip set product did not perform in compliance with specifications outlined in ansi/aami ec53:2013/ (r)2020 ecg trunk cables and patient leadwires.Specifically, the product did not meet section 5.3.9 *dielectric withstand voltage, which requires the assembly to withstand, without breakdown, an application of 5,000 v d.C.The product labeling (instructions for use) indicates compliance with the ec53 standard.Compliance with the standard is not required if the product is labeled "not defibrillation proof" in accordance with the labeling requirements provided in section 5.1.5 of the standard; however, the products do not contain such labeling.There have been no reports of adverse events or injuries related to the malfunction.Additionally, there have been no reports of the malfunction by any end users in the field.Attached is a technical analysis of the malfunction prepared by graphic controls dba nissha medical technologies/vermed/biomedical innovations.Note: this report being compiled and submitted by: graphic controls dba nissha medical technologies/vermed/biomedical innovations, the u.S.Agent.
|